EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Overview of the renin-angiotensin system in diabetic nephropathy

Farzaneh Karimi, Maryam Maleki, Ahmad Movahedpour, Mehdi Alizadeh, Ebrahim Kharazinejad, Mohammad Sabaghan

Journal of the Renin-Angiotensin-Aldosterone System · 2024-10 · 25

DOI: 10.1177/14703203241302966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 11.12.2024. Verfasst von Farzaneh Karimi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Behbahan Faculty of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a multifactorial hyperglycemic condition characterized by biochemical, molecular, and genetic variables, and leads to kidney dysfunction. Diabetic nephropathy (DN), referred to as diabetic kidney disease, is one of the major microvascular complications of diabetes, which is a major cause of end-stage renal disease and, consequently, high mortality. When DN occurs, it stimulates the renin-angiotensin system (RAS), one of the most significant indicators of developing renal impairment. Intrarenal RAS elements are upregulated in patients with DN, whereas systemic RAS elements are downregulated. Therefore, it is well accepted that the intra-renal RAS plays a key role in the onset of DN, characterized by the presence of protein in the urine and progressive decline in kidney function. RAS has two axes: 1- the renin, angiotensin-converting enzyme (ACE), angiotensin II (Ang II), and Ang II type 1 receptor (AT 1 R), 2- (ACE2, Ang 1-7, Ang 1-9, AT 2 receptor (AT 2 R), and Mas receptor (MasR). Blocking RAS with ACE inhibitors (ACEIs) and Ang II receptor blockers (ARBs) is currently a conventional therapy to protect the kidneys and inhibit DN progression and development in people with type 1 and type 2 diabetes.

Förderung

  • Behbahan Faculty of Medical Sciences

Zitieren

APA

Karimi, F., Maleki, M., Movahedpour, A., Alizadeh, M., Kharazinejad, E., & Sabaghan, M. (2024). Overview of the renin-angiotensin system in diabetic nephropathy. Journal of the Renin-Angiotensin-Aldosterone System, 25. https://doi.org/10.1177/14703203241302966

Vancouver

Karimi F, Maleki M, Movahedpour A, Alizadeh M, Kharazinejad E, Sabaghan M. Overview of the renin-angiotensin system in diabetic nephropathy. Journal of the Renin-Angiotensin-Aldosterone System. 2024;25. doi:10.1177/14703203241302966

BibTeX
@article{Karimi2024,
  author = {Karimi, Farzaneh and Maleki, Maryam and Movahedpour, Ahmad and Alizadeh, Mehdi and Kharazinejad, Ebrahim and Sabaghan, Mohammad},
  title = {Overview of the renin-angiotensin system in diabetic nephropathy},
  journal = {Journal of the Renin-Angiotensin-Aldosterone System},
  year = {2024},
  volume = {25},
  doi = {10.1177/14703203241302966}
}
Kostenlos starten →